Becton, Dickinson And Company income statement BDX

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, Becton, Dickinson And Company reported revenue of $21.8 billion, up 8.2% from the year before. Net income was $1.7 billion, a profit margin of 7.7%. Operating income came to $2.6 billion, an operating margin of 11.8%. Diluted earnings per share were $5.82. Over the twelve months ended Jun 30, 2026, revenue was $22.5 billion and net income was $942.0 million. Across the 10 fiscal years shown, revenue grew from $12.5 billion in fiscal 2016 to $21.8 billion in fiscal 2025, about 6.4% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Sep 30, 2025	FY 2024 Sep 30, 2024	FY 2023 Sep 30, 2023	FY 2022 Sep 30, 2022	FY 2021 Sep 30, 2021	FY 2020 Sep 30, 2020	FY 2019 Sep 30, 2019	FY 2018 Sep 30, 2018	FY 2017 Sep 30, 2017	FY 2016 Sep 30, 2016
Revenue	22,484 +18.5%	21,840 +8.2%	20,178 +4.2%	19,372 +2.7%	18,870 -1.4%	19,131 +19.0%	16,074 -7.0%	17,290 +8.2%	15,983 +32.2%	12,093 -3.1%	12,483 +21.4%
Cost of revenue	11,931 +12.6%	11,915 +7.8%	11,053 -1.3%	11,202 +7.8%	10,393 -1.0%	10,500 +13.2%	9,276 +3.0%	9,002 +3.3%	8,714 +42.2%	6,128 -5.6%	6,492 +16.2%
Gross profit	10,553 +25.9%	9,925 +8.8%	9,125 +11.7%	8,170 -3.6%	8,477 -1.8%	8,631 +13.9%	7,577 -8.6%	8,288 +14.0%	7,269 +22.3%	5,942 -0.8%	5,991 +27.6%
Research and development	1,301 +29.1%	1,265 +6.3%	1,190 -3.8%	1,237 -1.5%	1,256 -1.8%	1,279 +23.1%	1,039 -2.2%	1,062 +5.8%	1,004 +30.4%	770 -7.0%	828 +31.0%
Selling, general and administrative	5,546 +18.2%	5,278 +8.7%	4,857 +2.9%	4,719 +0.2%	4,709 -0.2%	4,719 +12.8%	4,185 -3.4%	4,332 +7.9%	4,016 +38.1%	2,909 -3.2%	3,005 +17.2%
Other operating income (expense)	-448 -117.5%	-396 -78.4%	-222 -205.7%	210 +667.6%	-37 +81.8%	-203 +44.1%	-363 +44.5%	-654	0 +100.0%	-410	—
Restructuring and impairment	693 +122.1%	275 -28.9%	387 +61.9%	239 +94.3%	123	—	—	—	—	85 -83.8%	526 +94.1%
Operating income	2,399 +18.4%	2,579 +7.6%	2,397 +13.5%	2,111 -7.5%	2,282 +1.4%	2,250 +146.7%	912 -48.2%	1,760 +16.6%	1,509 -0.9%	1,522 +6.4%	1,430 +33.1%
Interest income	23 -73.3%	38 -76.7%	163 +232.7%	49 +206.2%	16 +77.8%	9 +28.6%	7 -41.7%	12 -81.5%	65 -14.5%	76 +261.9%	21 +40.0%
Interest expense	—	613 +16.1%	528 +16.8%	452 +13.6%	398 -15.1%	469 -11.2%	528 -17.4%	639 -9.5%	706 +35.5%	521 +34.3%	388 +4.6%
Other non-operating income (expense)	46 +156.8%	-123 -339.3%	-28 +39.1%	-46 +60.7%	-117 -18.2%	-99 -530.4%	23 -46.5%	43 -85.9%	305 +402.0%	-101 -1018.2%	11 -47.6%
Pretax income	1,879 +32.3%	1,881 -6.2%	2,005 +20.6%	1,662 -6.8%	1,783 +5.4%	1,692 +71.8%	985 -16.2%	1,176 +0.3%	1,173 +20.2%	976 -9.1%	1,074 +45.3%
Income tax	231 -12.8%	203 -32.3%	300 +127.3%	132 -10.8%	148 +68.2%	88 +41.9%	62 +208.8%	-57 -106.6%	862 +795.2%	-124 -227.8%	97 +120.5%
Net income	942 -40.6%	1,678 -1.6%	1,705 +14.9%	1,484 -16.6%	1,779 -15.0%	2,092 +139.4%	874 -29.1%	1,233 +296.5%	311 -71.7%	1,100 +12.7%	976 +40.4%
Basic EPS	3.34 -39.2%	5.83 -0.9%	5.88 +18.3%	4.97 -16.2%	5.93 -14.3%	6.92 +151.6%	2.75 -31.4%	4.01 +546.8%	0.62 -86.8%	4.70 +2.4%	4.59 +33.8%
Diluted EPS	3.33 -39.3%	5.82 -0.7%	5.86 +18.6%	4.94 -16.0%	5.88 -14.2%	6.85 +152.8%	2.71 -31.2%	3.94 +556.7%	0.60 -87.0%	4.60 +2.4%	4.49 +34.0%
Weighted average shares, basic	282 -2.2%	288 -0.7%	290 +1.2%	286 +0.4%	285 -1.5%	289 +3.7%	279 +3.3%	270 +4.5%	258 +18.0%	219 +2.9%	213 +5.0%
Weighted average shares, diluted	283 -2.1%	289 -0.9%	291 +0.9%	288 +0.4%	287 -1.6%	292 +3.4%	282 +2.8%	275 +3.8%	265 +18.4%	224 +2.8%	218 +4.8%
Other measures
Depreciation and amortization	2,453 +7.0%	2,462 +7.7%	2,286 -0.1%	2,288 +2.6%	2,229 -0.0%	2,230 +5.4%	2,115 -6.1%	2,253 +13.9%	1,978 +81.8%	1,088 -2.3%	1,114 +25.0%
EBITDA	4,852 +12.3%	5,041 +7.6%	4,683 +6.5%	4,399 -2.5%	4,511 +0.7%	4,480 +48.0%	3,027 -24.6%	4,013 +15.1%	3,487 +33.6%	2,610 +2.6%	2,544 +29.5%
Interest coverage	—	4.21x	4.54x	4.67x	5.73x	4.80x	1.73x	2.75x	2.14x	2.92x	3.69x
Margins
Gross margin	46.94%	45.44%	45.22%	42.17%	44.92%	45.12%	47.14%	47.94%	45.48%	49.14%	47.99%
Operating margin	10.67%	11.81%	11.88%	10.90%	12.09%	11.76%	5.67%	10.18%	9.44%	12.59%	11.46%
Pretax margin	8.36%	8.61%	9.94%	8.58%	9.45%	8.84%	6.13%	6.80%	7.34%	8.07%	8.60%
Profit margin	4.19%	7.68%	8.45%	7.66%	9.43%	10.94%	5.44%	7.13%	1.95%	9.10%	7.82%
EBITDA margin	21.58%	23.08%	23.21%	22.71%	23.91%	23.42%	18.83%	23.21%	21.82%	21.58%	20.38%
Effective tax rate	12.29%	10.79%	14.96%	7.94%	8.30%	5.20%	6.29%	-4.85%	73.49%	-12.70%	9.03%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: BDX (NYSE)
Fiscal year ends: September 30
Incorporated in: NJ
Headquarters: Franklin Lakes, NJ
SEC filer status: Large accelerated filer
SEC CIK: 10795

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.